Based on the Alzamend Neuro Inc stock forecast from 0 analysts, the average analyst target price for Alzamend Neuro Inc is not available over the next 12 months. Alzamend Neuro Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Alzamend Neuro Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Alzamend Neuro Inc’s stock price was USD 0.70. Alzamend Neuro Inc’s stock price has changed by +4.63% over the past week, -31.27% over the past month and -90.12% over the last year.
No recent analyst target price found for Alzamend Neuro Inc
No recent average analyst rating found for Alzamend Neuro Inc
Company Overview Alzamend Neuro Inc
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company has partnership agreement with Massachusetts General Hospital for the Phase II clinical trial of AL001. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. Read Less
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for...Read More
Frequently Asked Questions About Alzamend Neuro Inc (ALZN) Stock
Stock Target Advisor's fundamental analysis for Alzamend Neuro Inc's stock is Very Bearish.
Unfortunately we do not have enough data on ALZN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ALZN's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ALZN's stock to indicate if its overvalued.
The last closing price of ALZN's stock was USD 0.70.
The most recent market capitalization for ALZN is USD 6.99M.
Unfortunately we do not have enough analyst data on ALZN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Alzamend Neuro Inc's stock.
As per our most recent records Alzamend Neuro Inc has 4 Employees.
Alzamend Neuro Inc's registered address is 3480 Peachtree Road NE, Atlanta, GA, United States, 30326.
You can get more information about it from Alzamend Neuro Inc's website at https://www.alzamend.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Alzamend Neuro Inc (ALZN) Stock
Stock Target Advisor's fundamental analysis for Alzamend Neuro Inc's stock is Very Bearish.
Unfortunately we do not have enough data on ALZN's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ALZN's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ALZN's stock to indicate if its overvalued.
The last closing price of ALZN's stock was USD 0.70.
The most recent market capitalization for ALZN is USD 6.99M.
Unfortunately we do not have enough analyst data on ALZN's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Alzamend Neuro Inc's stock.
As per our most recent records Alzamend Neuro Inc has 4 Employees.
Alzamend Neuro Inc's registered address is 3480 Peachtree Road NE, Atlanta, GA, United States, 30326.
You can get more information about it from Alzamend Neuro Inc's website at https://www.alzamend.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ALZN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
